Table 3.

Characteristics of prostate cancer cases in the cohort (N = 383)

CharacteristicProstate cancer cases
Clinical TNM tumor stage, number (%)
 T1c (N0/x, M0/x)228 (59.5)
 T2a (N0/x, M0/x)67 (17.5)
 T2b/c (N0/x, M0/x)68 (17.8)
 T3a (N0/x, M0/x)5 (1.3)
 T3b (N0/x, M0/x)3 (0.8)
 N10 (0.0)
 M18 (2.1)
Gleason score, number (%)
 ≤G3+3214 (55.9)
 G3+485 (22.2)
 G4+338 (9.7)
 ≥G4+448 (12.3)
Serum PSA level (ng/mL)
 ≤10.0273 (71.3)
 10.1–20.056 (14.6)
 >20.054 (14.1)
NCCN risk strata
 Very low/low150 (39.2)
 Intermediate142 (37.1)
 High/very high91 (23.8)
Tumor type
 Prostate adenocarcinoma383 (100)

Abbreviation: NCCN, 2007 NCCN Prostate Cancer Guidelines.